Paul W. Pitts

Partner

“Paul is an expert in the field and provides well-reasoned and thoughtful advice that measures risk and opportunity extremely well.”

Chambers USA, Healthcare client

Paul advises health care providers and life sciences companies on regulatory matters and business transactions. Clients turn to him for guidance on compliance with fraud and abuse laws, payment and coverage rules, privacy and security laws, and participation in Medicare and Medicaid programs. Paul works with all types of health care and life sciences organizations – from startups to public companies – throughout the lifecycle of a company or an investment. He also serves as managing partner of Reed Smith’s Silicon Valley office.

With a focus on finding practical solutions, Paul advises clients on business and regulatory considerations in strategic transactions and contractual arrangements. He has extensive experience in negotiating and drafting agreements between health care entities, forming joint ventures, advising on investments in startups, and counseling clients on vertically integrated models of care. He has represented buyers and sellers in major acquisitions in the life sciences and health care industry, focusing on due diligence, change of ownership issues, regulatory approvals, risk mitigation, and business integration.

Paul also advises clients on internal investigations, including allegations of false claims or other noncompliance with federal and state law. He has represented all types of health care providers in disclosing and refunding Medicare overpayments and assisted in the defense of false claims investigations brought by the Department of Justice and the Office of Inspector General.

Experience

Representative matters

Served as co-counsel to McKesson Corporation in its agreement with CD&R to acquire Option Care Health, Inc., a national provider of home and alternate site infusion services, at a total enterprise value of $5.8 billion. Under the agreement, McKesson will invest $1.4 billion for a 49% stake and has a framework to later acquire CD&R’s interest.
Advised McKesson on health care and privacy regulatory matters and due diligence in connection with McKesson’s agreement to acquire Precision Medicine Group, LLC, a global provider of clinical research and biopharma commercialization services, in a transaction valued at approximately $2.25 billion.
Led complex health care regulatory due diligence for McKesson in its acquisition of a controlling interest in Community Oncology Revitalization Enterprise Ventures, LLC, a business and administrative services organization established by Florida Cancer Specialists & Research Institute, LLC, a leading physician owned community oncology practice.

Recognitions

  • Recognized in the prestigious, client-selected Thomson Reuters Stand-Out Lawyers listing for 2026

  • Named by The Daily Journal as a Top Health Care Lawyer, 2019, 2023
  • Ranked in Chambers USA for California Healthcare, 2018-2026

Credentials

Education

  • Tulane Law School, 2003, J.D.
  • Tulane University, 2003, MHA (Masters in Health Administration), School of Public Health & Tropical Medicine
  • Purdue University, 1997, B.A., Political Science, Phi Beta Kappa
  • Purdue University, 1997, B.S., Business Management

Professional admissions & qualifications

  • Louisiana
  • California

Professional affiliations

  • American Bar Association Health Law Section; Chair of Life Sciences Interest Group
  • American Bar Association Health Law Section; Former Vice Chair of Life Sciences Interest Group
  • American Health Lawyers Association; Active Member
  • California Society for Professionals in Healthcare; Former Board Member
  • California Society for Healthcare Attorneys; Active Member
  • Purdue Alumni Association; Life Member, Former Board Member
  • Radiology Business Management Association; Former Member of Federal Affairs Committee
  • Women’s Community Clinic; Board Member, 2012-present

News

Media mentions

Blogs

Events